Rhythm Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
RYTM chart
What traders are saying about $RYTM
Latest postsRhythm Pharmaceuticals, Inc. news
- Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo Finance ·
- How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Japan Drug Launch
Simply Wall Street ·
- Rhythm Pharmaceuticals (RYTM) Launched IMCIVREE In Japan, Is It Still A Bargain?
Simply Wall Street ·
- Rhythm Pharmaceuticals, Inc. Estimates – NASDAQ:RYTM
TradingView ·
- Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years
Benzinga ·
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
Yahoo Finance ·
- Rhythm Pharmaceuticals to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
Yahoo Finance ·
- Two healthcare conferences will feature Rhythm’s CEO and CFO after its Nov. 3 results call.
Stock Titan ·
- Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
Yahoo Finance ·
- Rhythm Pharmaceuticals (RYTM) Upgraded to Buy: Here's What You Should Know
Yahoo Finance ·
- How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Progress In Prader-Willi And Genetically Defined Obesity Therapies
Yahoo Finance ·
- Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight
Yahoo Finance ·
Rhythm Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $189.8M | $130.1M | $77.4M | $23.6M |
| Net income | -$196,539 | -$260,602 | -$184,678 | -$181,119 |
| Diluted EPS | $-3.11 | $-4.34 | $-3.20 | $-3.47 |
| Total assets (year end) | $480.2M | $392.3M | $332.7M | $382.5M |
| Cash and equivalents (year end) | $54.3M | $89.1M | $60.1M | $127.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rhythm Pharmaceuticals, Inc.
- Ticker
- RYTM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1649904
- Former names
- RHYTHM METABOLIC, INC.
Frequently asked questions
What exchange is Rhythm Pharmaceuticals, Inc. listed on?
Rhythm Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol RYTM.
What industry is Rhythm Pharmaceuticals, Inc. in?
Rhythm Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rhythm Pharmaceuticals, Inc. headquartered?
Rhythm Pharmaceuticals, Inc.'s business address on file with the SEC is in Boston, MA.
When does Rhythm Pharmaceuticals, Inc.'s fiscal year end?
Rhythm Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Rhythm Pharmaceuticals, Inc. report?
Rhythm Pharmaceuticals, Inc. reported $189.8M in revenue for calendar year 2025, according to its SEC filings.